GM1 ganglioside administration protects spinal neurons after glutamate excitotoxicity

Restorative Neurology and Neuroscience

Volumn 14, Issue 1, 1999, Pages 47-51

  Vorwerk, Christian K ^a,d,e   Bonheur, Jennifer ^d   Kreutz, Michael R ^b,c   Dreyer, Evan B ^a   Laev, Heljo ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^d Columbia University ^*  (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ganglioside; Glutamate; Immunohistochemistry; In vitro; LDH; Spinal cord

Indexed keywords

GANGLIOSIDE GM1;

ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; MEMBRANE DAMAGE; MEMBRANE STRUCTURE; MOUSE; NERVE CELL LESION; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD INJURY;

EID: 0032901935     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Anderson, D.K Antioxidant therapy in experimental spinal cord injury. Restor. Neural. Neurosci. 2 (1991) 169-174
2. Avora, N.F., Victorov, I.V., Tyunn. V.A., Zakharova, I.O , Sokolova, T.V , Andreeva, N.A., Stelmaschuk, E.V., Tyurina, Y.Y., Gonchar, V.S. Inhibition of glutamate-induced intensification of free radical reactions by gangliosides: possible role in their protective effect in rat cerebellar granule cells and brain synaptosomes. Neurochem. Res. 23:7 (1998) 945-952.
3. Bonheur, J.L., Laev, H., Vorwerk, C.K. and Karpiak, S.E. Traumatic injury of spinal cord cells in vitro reduced by GM1 ganglioside, Restor Neural. Neurosci. 6 (1994) 127-133
4. Choi, D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-643.
5. Dawson, T.M., Hung, K., Dawson, V.L., Steiner, J.P. and Snyder, S.H. Neuroprotective effects of gangliosides may involve inhibition of nitric oxide synthase. Ann. Neural. 37 (1995) 115-118.
6. Di, X., Harpold, J.C., Watson, J.C., Bullock, M.R. Excitotoxic damage in neurotrauma: fact or fiction. Restor. Neural. Neurosci. 9 (1996) 231-241.
7. Faden, A.I. and Simon, R.P. A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann. Neural. 23 (1988) 623-626.
8. Faden, A.I. Demediuk, P., Panter, S.S. and Vink, R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244 (1989) 798-800
9. Farooque, M., Hillered, L., Holtz, A. and Olsson, Y. Effects of moderate hypothermia on extracellular lactic acid and amino acids after severe compression injury of rat spinal cord. J. Neurotrauma 14 (1997) 63-69.
10. Geisler, F.H., Dorsey, F.C. and Coleman, W.P. Recovery of motor function after spinal cord injury - a randomized, placebo-controlled trial with GM1 ganglioside. N. Engl J. Med. 324 (1991) 1829-1838
11. Geisler, F.H., Dorsey, F.C. and Coleman, W.P. GM1 ganglioside in human spinal cord injury. J. Neurotrauma 9 (1992) 517-530.
12. Hicks, D., Heidinger, V., Mohand-Said, S., Sahel, J. and Dreyfus, H. Growth factors and gangliosides as neuroprotective agents in excitotoxicity and ischemia. Gen. Pharmacol 30 (3) (1998) 265-273.
13. Hoffman, P.L., Iorio, K R., Snell, L.D., Tabakoff, B Attenuation of glutamate-induced neurotoxicity in chronically ethanol-exposed cerebellar granule cells by NMDA receptor antagonists and ganglioside GM1. Alcohol Clin. Exp. Res. 19:3 (1995) 721-726.
14. Imanaka, T., Hukuda, S. and Maeda, T. The role of GM1-ganglioside in the injured spinal cord of rats: an immunohistochemical study using GM1-antisera. J Neurotrauma 13 (1996) 163-170.
15. Ishikawa, T. and Marsala, M. Excitatory amino acids and prostanoids release in spinal cord injury. No To Shinkei 48 (1996) 259-263.
16. Jorgensen, O.S. and Stein, D.G. Transplant and GM1 mediated neuronal recovery in rats with brain lesions. Restor. Neural. Neurosci 3 (1992) 311-320.
17. Karpiak, S.E. and Mahadik, S.P. Gangliosides reduction of ischemic injury. Critical Review in Neurobiol. 5 (1990) 221-237.
18. Katayama, Y., Becker, D.P., Tamura, T. and Hovda, D.A. Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J Neurosurg. 73 (1990) 889-900.
19. Koh, J.Y. and Choi. D W. Quantitative determination of glutamte mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux essay. J. Neurosci Method 20 (1990) 83-90.
20. Kwak, S. and Nakamura R. Acute and late neurotoxicity in the rat spinal cord in vivo induced by glutamate receptor agonists J Neurol. Sci. 129 (1995) 99-103
21. Laev, H, and Mahadik, S.P. Topography of monosialoganglioside (GM1) in rat brain using monoclonal antibodies. Neurosci Lett 102 (1989) 7-14.
22. Laev, H., Mabadik, S P., Bonheur, L., Hernandez N and Karpiak, S E. GM1 ganglioside reduces glutamate toxicity to cortical cells. LDH relaese and preserved membrane integrity. Mol. Chem. Neuropathology 20 (1993) 229-243.
23. Mahadik, S.P. and Karpiak, S.E Ganghoside treatment of neuronal injury and disease Drug Dev. Res. 15 (1988) 337-369
24. Mahadik, S.P, Makar, P.K., Murthy, J.N., Ortiz, A., Wakade, C.G. and Karpiak, S.E Temporal changes in levels of Superoxide dismutase, glutathione peroxidase and catalase in primary and peri-ischemic tissue monosialoganglioside (GM1) treatment effects. Mol Chem. Neuropathol. 18 (1993) 1-14.
25. McIntosh, T.K, Smith, D.H. and Garde, E. Therapeutic approaches for the prevention of secondary brain injury. Eur. J. Anaesthesiol. 13 (1996) 291-309.
26. Mattson, M.P. and Furukawa, K. Programmed cell life: anti-apoptotic signaling and therapeutic strategies for neurodegenerative disorders. Restor Neurol. Neurosci. 9 (1996) 191-205.
27. Mori, A., Ueda, T, Nakamichi, T., Yasudo, M., Aeba R., Odaguchi, H., Mitsumaru, A., Ito, T., Yozu, R., Koto, A., Kawada, S. Detrimental effects of exogenous glutamate on spinal cord neurons during brief is-chemia in vivo. Ann. Thorac. Surg. (4) 63 (1997) 1057-1062.
28. Nilsson, P., Hillered, L., Ponten. U. and Ungerstedt, U. Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats. J. Cereb. Blood Flow Metab. 10 (1990) 631-637.
29. Okazaki, S., Nishida, Y., Kawai, H , Saito, S. Acute neurotoxicity of L-glutamate induced by impairment of the glutamate uptake system. Neurochem. Res. 21 (10) (1996) 1201-1207.
30. Puka-Sundvall, M., Sandberg, M. and Hagberg, H. Brain injury after hypoxia-ischemia in newborn rats: relationship to extracellular levels of excitatory amino acids and cysteine Brain Rex. 750 (1997) 325-328.
31. Ransom, B.R., Neale, E , Henkart, M., Bolluck, P.N. and Nelson, P.G. Mouse spinal cord in cell culture. I. Morphology and intrinsic neuronal electrophysiologic properties. J. Neurophysial 40 (1977) 1132-1150
32. Rothstein, J.D. and Kuncl, R.W. Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J. Neurochem. 65 (2) (1995) 643-651.
33. Sautter, J , Schwartz, M., Duvdevani, R. and Sabel, B.A GM1 ganglioside treatment reduces visual deficits after graded crush of the rat optic nerve Brain Res 565 (1991) 23-33.
34. Segatore, M and Way, C. Neuroprotection after spinal cord injury: state of the science. SCI Nurs 14 (1997) 8-18.
35. Skaper, S.D , Facci, L and Leon, A. Gangliosides attenuate the delayed neurotoxicity of aspartic acid in vitro. Neurosci Lett. 117 (1990) 154-159.
36. Taoka, Y and Okajima, K Spinal cord injury in the rat Prog. Neurobiol. 56 (1998) 341-358.
37. Willinger, M. and Schachner, M. GM1 ganglioside as a marker for neuronal differentiation in mouse cerebellum. Dev. Biol. 74 (1980) 101-117